Categories: News

Cango Inc. Closed the US$10.5 Million Equity Investment and Secured US$65 Million Additional Equity Investments

DALLAS, Feb. 12, 2026 /PRNewswire/ — Cango Inc. (NYSE: CANG) (“Cango” or the “Company”), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that it closed the previously announced US$10.5 million equity investment from Enduring Wealth Capital Limited (“EWCL”), and entered into definitive agreements with entities wholly-owned by Mr. Xin Jin, Chairman of the Company, and Mr. Chang-Wei Chiu, a director of the Company, pursuant to which these entities agreed to make equity investments in the aggregate amount of US$65 million in the Company.

- Advertisement -

As previously announced, the Company entered into an investment agreement with EWCL on December 29, 2025, and recently issued 7 million Class B ordinary shares, each carrying 20 votes per share, to EWCL at US$1.50 per share (the “Class B Investment”). After closing, EWCL’s beneficial ownership increased from approximately 2.81% to approximately 4.71% of the Company’s total outstanding ordinary shares, and its voting power rose from approximately 36.68% to 49.71% of the total voting power.

- Advertisement -

To reaffirm their confidence in the Company’s strategic trajectory and future prospects, Mr. Jin and Mr. Chiu indicated their intent to make equity investments. With the approval of the audit committee and the board of directors, the Company entered into (i) an investment agreement with Fortune Peak Limited (“FPL”), wholly owned by Mr. Chiu, pursuant to which FPL agrees to subscribe for 29,975,137 Class A ordinary shares, each carrying one vote per share, for an aggregate of US$39,567,181 (the “Mr. Chiu Class A Investment”), and (ii) an investment agreement with Armada Network Limited (“ANL”), wholly owned by Mr. Jin, for 19,267,287 Class A shares for an aggregate of US$25,432,819 (the “Mr. Jin Class A Investment”). The purchase price, US$1.32 per share, was determined with reference to the closing price of the Company’s Class A shares over the preceding four weeks.

- Advertisement -

Upon completion, Mr. Chiu is expected to hold approximately 11.99% of the total outstanding shares and 6.71% of the voting power; Mr. Jin approximately 4.70% and 2.63%, respectively. Closing of each investment is subject to customary conditions and regulatory approvals, with both expected to close in February 2026.

- Advertisement -

The Company intends to use the proceeds from these investments to support its expansion into AI and computing infrastructure, while further strengthening its balance sheet.

- Advertisement -

Investor Relations Contact
Juliet Ye, Head of Communications
ir@cangoonline.com 

- Advertisement -

Logo – https://mma.prnewswire.com/media/2675436/5793745/CANG_LOGO_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cango-inc-closed-the-us10-5-million-equity-investment-and-secured-us65-million-additional-equity-investments-302686167.html

- Advertisement -

Recent Posts

Pinecone Launches First Serverless Region in Asia with New Singapore Cloud Region, Bringing the Knowledge Infrastructure for AI to the Asia-Pacific Market

Alongside new availability on AWS ap-southeast-1, Pinecone announces Nexus knowledge engine, KnowQL query language, Marketplace,…

16 minutes ago

Kroll Appoints Renowned Professional Services Executive Fred Crawford as Executive Chairman

Fred Crawford brings decades of experience building and scaling advisory firms to help support and…

16 minutes ago

Maropost Launches a New Partner Portal to Supercharge Global Growth

TORONTO, May 4, 2026 /PRNewswire/ -- Maropost, the leading unified commerce platform, today announced the…

16 minutes ago

Lee Cowie appointed CEO of accesso as company accelerates AI strategy

COO steps up as founder Steve Brown passes the baton in planned handover; transition follows…

16 minutes ago

Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf…

1 hour ago

Making Waves Across Borders: Manipal Hospitals Presents the First-Ever Sri Lanka-India Open Water Swim by a Couple

BENGALURU, India, May 4, 2026 /PRNewswire/ -- Manipal Hospitals, India's largest pan-India multispecialty hospital network by…

1 hour ago